218 related articles for article (PubMed ID: 31987636)
1. Survival after reoperation for recurrent glioblastoma.
Woodroffe RW; Zanaty M; Soni N; Mott SL; Helland LC; Pasha A; Maley J; Dhungana N; Jones KA; Monga V; Greenlee JDW
J Clin Neurosci; 2020 Mar; 73():118-124. PubMed ID: 31987636
[TBL] [Abstract][Full Text] [Related]
2. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
4. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
5. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.
Tully PA; Gogos AJ; Love C; Liew D; Drummond KJ; Morokoff AP
Neurosurgery; 2016 Nov; 79(5):678-689. PubMed ID: 27409404
[TBL] [Abstract][Full Text] [Related]
6. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
7. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
8. Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.
Fariña Nuñez MT; Franco P; Cipriani D; Neidert N; Behringer SP; Mader I; Delev D; Fung C; Beck J; Sankowski R; Nicolay NH; Heiland DH; Schnell O
J Neurooncol; 2020 Jan; 146(2):381-387. PubMed ID: 31933259
[TBL] [Abstract][Full Text] [Related]
9. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
10. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
[TBL] [Abstract][Full Text] [Related]
11. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
Coburger J; Wirtz CR; König RW
J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
13. Impact of Early Reoperation on the Prognosis of Patients Operated on for Glioblastoma.
Troya-Castilla M; Kaen A; Márquez-Rivas FJ; Infante-Cossio P; Rius Díaz F; Narros Gimenez JL; Gonzalez-Pombo M; Cancela P; Segura Fernández-Nogueras M; Arráez Sánchez MÁ
World Neurosurg; 2020 Jul; 139():e592-e600. PubMed ID: 32330620
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Boxerman JL; Zhang Z; Safriel Y; Rogg JM; Wolf RL; Mohan S; Marques H; Sorensen AG; Gilbert MR; Barboriak DP
Neuro Oncol; 2018 Sep; 20(10):1400-1410. PubMed ID: 29590461
[TBL] [Abstract][Full Text] [Related]
15. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
17. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
18. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
19. Multiple resections for patients with glioblastoma: prolonging survival.
Chaichana KL; Zadnik P; Weingart JD; Olivi A; Gallia GL; Blakeley J; Lim M; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2013 Apr; 118(4):812-20. PubMed ID: 23082884
[TBL] [Abstract][Full Text] [Related]
20. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
